Stock Analiz

Advanced Biomed Inc. ADVB

Medical Specialities · IPO 2025 · data as of November 13, 2026

$2.53Market cap $4M
Open the interactive analysis →

Advanced Biomed Inc. (ADVB) is a healthcare company listed in the US with a market value of about $4M.

Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is financial health (4/5); the weakest is future growth (0/5).

Key numbers: a P/E of 0.7, a 5-year average ROIC of -38%.

About Advanced Biomed

Advanced Biomed is listed in the US and classified in medical specialities, IPO year 2025. It was profitable in 1 of the last 3 years in our data.

Score: 1.4 / 5

Value2/5
Future growth0/5
Track record1/5
Financial health4/5
Shareholder returns0/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • ROE above 15%
  • More cash than debt, or low debt to equity
  • Interest covered more than 5 times
  • Debt below 3 years of free cash flow
  • Liabilities below 60% of assets

Checks not passed

  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)0.7
Forward P/E—
P/FCF—
P/S—
P/B0.4
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield—
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)—
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)—
ROIC (5-yr avg.)-37.6%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 3 years

Fiscal year202620252024
Revenue———
Net income$7M-$3M-$3M
Free cash flow—-$6M-$2M
EPS (diluted)$5.33$-3.18$-2.80
Net margin———
ROIC-50.8%-24.4%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

What is Advanced Biomed’s P/E ratio?

About 0.7, based on the last twelve months of diluted earnings per share.

Does Advanced Biomed pay a dividend?

Not currently.

Is Advanced Biomed a good stock to buy?

We do not give buy or sell advice. Advanced Biomed scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.